About this trial
Study to comparing conventrional antibiotic strategies versus regimens guided by epidemiological surveillance in infected patients with cirrhosis.
Eligibility criteria
Qualifiers
Cirrhotic patients with acute decompensation aged ≥18 years.
Proven or suspected bacterial infection requiring antibiotic therapy (diagnosis will be established according to local guidelines, Appendix 1).
Signed informed consent or consent given by their legal representatives or close relatives.
Disqualifiers
Bacterial infection lasting for > 48 hours.
Infection in a critically ill cirrhotic patient (ICU admission). In this population, epidemiological surveillance is standard clinical practice.
Evidence of current locally advanced or metastatic malignancy (patients with hepatocellular carcinoma within the Milan criteria and non-melanocytic skin cancer can be included).
Pregnant and/or breast-feeding woman.
Trial design
Treatments tested in this trial
- Conventional antibiotic strategies
- Regimens guided by epidemiological surveillance
Treatment groups
Sponsors and collaborators
Eva Bonfill
Lead sponsor
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Sponsor institution